Sun Pharma Recalls 400,000 Bottles of Drugs in U.S., FDA Says
This article is for subscribers only.
Sun Pharmaceutical Industries Ltd., India’s largest drugmaker by market value, is recalling almost 400,000 bottles of anti-depressant and antihistamine medications in the U.S. because the pills failed to dissolve properly.
The recall is the latest in a string by Indian companies that has led to increased scrutiny from regulators concerned that the quality of drugs made in that country aren’t up to U.S. standards. The concerns prompted Margaret Hamburg, the commissioner of the U.S. Food and Drug Administration, to go to India in February to meet with pharmaceutical makers there about production quality.